Is Apollo Hospitals (APOLLOHOSP) overvalued or fairly valued?

MarketChacha shows Apollo Hospitals's valuation in context — a forward P/E of about 41.2, a price-to-book of about 13.4 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Apollo Hospitals's revenue?

Apollo Hospitals reported revenue of ₹9,326 Cr for FY2026, with net profit of ₹1,493 Cr, per official filings.

What is the share price of Apollo Hospitals (APOLLOHOSP)?

Apollo Hospitals last traded at ₹8,820.00 (-1.9% on the day), as of 8/3/2026 — a delayed quote shown for education, not investment advice.

Apollo Hospitals

APOLLOHOSP · NSE · Healthcare · India

Snapshot

TickerAPOLLOHOSP

ExchangeNSE

SectorHealthcare

IndustryMedical Care Facilities

CountryIndia

Employees44,008

HeadquartersChennai, India

Websitewww.apollohospitals.com

Filings tracked3

About Apollo Hospitals

Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics, urology, organ transplantation, pulmonology, obstetrics and gynecology, internal medicine, vascular surgery, pediatrics, cosmetology, emergency medicine, bariatric surgery, general surgery, colorectal surgery, dentistry, nephrology, dermatology, endocrinology, preventive medicine, interventional radiology, ophthalmology, and integrative medicine, as well as robotic surgery and genomics. The company also provides project consultancy, medical educational institutes, Medvarsity for e-learning, and research services, as well as acts as an agent for life, general, and health insurance. In addition, it operates hospitals, pharmacies, primary care clinics, and diagnostic centers; short stay facilities, boutique birthing centers, multi-specialty clinics, dental and dialysis facilities, and preventive care; day surgery, diabetes management, and cradle and fertility centers; and Apollo 24/7, a digital health mobile platform that provides teleconsultations, online pharmacy deliveries, home diagnostics, and insurance services. Further, the company engages in the business of bio-banking of tissues. It serves patients, corporate clients, and the government and public sectors. Apollo Hospitals Enterprise Limited was incorporated in 1979 and is based in Chennai, India.

Who owns it

Promoters28.4%
Institutions49.4%
Public & other22.2%

296 institutional holders

Ownership breakdown from public market data. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Net margin trend4.9% → 16.0%

Margin has expanded by about 11.1 points — the business is getting more profitable.

Growth qualityrev -18% · PAT 22%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (BSE (official results filing)). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev ₹7,361 Cr · EPS 40.91

Est. earnings growth +23.2%

Next fiscal year

Rev ₹35,046 Cr · EPS 214.33

Est. earnings growth +27.3%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: BSE (official results filing)

Annual

Quarterly · last 4

Revenue (FY2026)

₹9,326 Cr

Net margin

16.0%

Revenue CAGR (3y)

-17.5%

Profit CAGR (3y)

+22.1%

EPS (FY2026)

103.81

Net profit (FY2026)

₹1,493 Cr

Ask MarketChacha about APOLLOHOSP

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

On MarketChacha

Posts about APOLLOHOSP

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin
FY2026	₹9,326 Cr	₹1,493 Cr	103.81	16.0%
FY2025	₹21,794 Cr	₹1,446 Cr	—	6.6%
FY2024	₹19,059 Cr	₹899 Cr	—	4.7%
FY2023	₹16,612 Cr	₹819 Cr	—	4.9%

Quarterly

Period	Revenue	Net profit	Net margin
2026Q1	₹6,606 Cr	₹529 Cr	8.0%
2025Q4	₹6,477 Cr	₹502 Cr	7.8%
2025Q3	₹6,304 Cr	₹477 Cr	7.6%
2025Q2	₹5,842 Cr	₹433 Cr	7.4%

Figures as reported, in ₹ (crore). Source: BSE (official results filing).

Filings & announcements

2026

Board Meeting Intimation for Notice Of The Board Meeting
Apollo Hospitals Enterprise Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve as per annexure enclosed
BSE7/16/2026material
Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting
as per annexure enclosed
BSE6/24/2026
Scheme of Arrangement
As per annexure enclosed
BSE6/24/2026

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.